Year | Volume (Price x Shares) | Change |
---|---|---|
2024 | $19.91 M | -83.48% |
2023 | $0.12 B | 113.2% |
2022 | $56.53 M | -68.82% |
2021 | $0.18 B | 692.67% |
2020 | $22.87 M | -91.87% |
2019 | $0.28 B | -34.7% |
2018 | $0.43 B | 582.42% |
2017 | $63.16 M | 35.85% |
2016 | $46.49 M | 196.68% |
2015 | $15.67 M | 54.27% |
2014 | $10.15 M | 537.98% |
2013 | $1.59 M |
Company | FTD volume (3months) | FTD volume (1 year) | Country |
---|---|---|---|
Johnson & Johnson JNJ | $28.5 M | $0.59 B | ๐บ๐ธ USA |
Novartis NVS | $20.77 M | $81.53 M | ๐จ๐ญ Switzerland |
Pfizer PFE | $13.91 M | $0.31 B | ๐บ๐ธ USA |
Amgen AMGN | $52.24 M | $0.21 B | ๐บ๐ธ USA |
Sanofi SNY | $29.8 M | $76.77 M | ๐ซ๐ท France |
Merck MRK | $5.8 M | $0.14 B | ๐บ๐ธ USA |
GlaxoSmithKline GSK | $17.9 M | $24.11 M | ๐ฌ๐ง UK |
Seagen
SGEN | N/A | $34.5 M | ๐บ๐ธ USA |
Dr. Reddy's RDY | $2.89 M | $11.2 M | ๐ฎ๐ณ India |